Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Cytochrome P450 reductase (POR) is a membrane-bound diflavin oxidoreductase that catalyzes the transfer of electrons from NADPH to all microsomal cytochrome P450 enzymes and other endoplasmic reticulum-associated heme proteins, such as heme oxygenase. It contains both FAD and FMN cofactors within distinct domains and is essential for the activity of cytochrome P450s in the metabolism of drugs, steroids, lipids, and xenobiotics. In humans, the POR gene is located on chromosome 7q11.23. Structural flexibility, enabled by hinge regions between domains, allows POR to interact with multiple cytochrome P450 isoforms and deliver electrons sequentially, facilitating the catalytic activities of these enzymes in detoxification and biosynthetic processes. Mutations in POR can cause disorders including altered steroidogenesis, skeletal malformations, and atypical drug responses due to changes in cytochrome P450–mediated metabolism
Facilitates electron transfer from NADPH to microsomal cytochrome P450 enzymes and other heme proteins, enabling enzymatic activity such as hydroxylation, demethylation, and epoxidation in xenobiotic and endobiotic metabolism
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Cytochrome P450 reductase (POR).